Brockton NAACP Forum – BCA TV
[su_youtube url=”https://www.youtube.com/watch?v=hv8fgetucDo&feature=youtu.be” mute=”yes”] Learn More
Prostate Cancer Awareness Day in Brockton, MA Sept 15, 2019
Prostate Cancer Awareness Forum on BCA-TV More
Grand Rounds in Urology – Panel on Women in Urology
Panel on Women in Urology
Brockton Community Access – NAACP Prostate Cancer Awareness 3-14-19
NAACP Prostate Cancer Awareness 3-14-19
Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study
August 2, 2016 Vincent J. Gnanapragasam [ultimate_spacer height=”32″] Abstract Introduction Over 80% of the nearly 1 million men diagnosed with prostate cancer annually worldwide present with localised or locally advanced non-metastatic disease. Risk stratification is the cornerstone for clinical decision making and treatment selection for these men. The most widely applied stratification systems use presenting…
Prostate cancer breakthrough could lead to new diagnostic tests and treatments
PUBLIC RELEASE: 28-JUL-2016 Full Article Prostate cancer patients have been offered hope after scientists at Newcastle University, UK, have identified a new group of molecules that could be targeted to slow tumor growth. Experts used an advanced screening technique which found hundreds of genes were affected by the male hormone testosterone. It is believed this could…
Protein ZMYND8 tied to suppression of prostate cancer tumor metastasis
PUBLIC RELEASE: 28-JUL-2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Study reveals protein’s ability to block expression of metastasis-linked genes UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER PUBLIC RELEASE: 28-JUL-2016 Although it reads like European license plate number, a protein known as ZMYND8 has demonstrated its ability to block metastasis-linked genes in prostate cancer, according to a study at…
Patients with low risk prostate cancer on active surveillance experience good quality of life
New York, NY, July 25, 2016 Researchers found no significant differences in health related quality of life between patients with low risk prostate cancer on active surveillance and men without the disease over 3 years of followup, according to new study in the Journal of Urology ELSEVIER HEALTH SCIENCES [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Active surveillance…
Switch from observation only to active treatment by prostate cancer patients varies by race/ethnicity
New York, NY, July 27, 2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Assessment of clinical and nonclinical factors indicates that black men on active surveillance are more likely to pursue active treatment, according to a new study published in The Journal of Urology® ELSEVIER HEALTH SCIENCES Although active surveillance, or watchful waiting, for patients with low risk…
New findings concerning hereditary prostate cancer
Date: July 11, 2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] It is a well-known fact that men with a family history of prostate cancer run an increased risk of developing the disease. The risk for brothers of men with prostate cancer is doubled. But a doubled risk of what, exactly? Prostate cancer my be an indolent condition…